{'fraction_non_alphanumeric': 0.04527162977867203, 'fraction_numerical': 0.019114688128772636, 'mean_word_length': 5.909722222222222, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Statins and Musculoskeletal Pain

DOI: 10.1097/NOR.0b013e318274cd9e National Center for Health Statistics). Participants were included if they experienced musculoskeletal pain (in the past month) that lasted more than 24 hours. Buettner et al. assessed participants’ reports of pain at four different regions: neck or upper back; upper extremities (shoulder, arm, wrist, or hand); lower back; and lower extremities (buttock, leg, or foot). Researchers also collected data on participants’ age, sex, race/ethnicity, smoking status, physical activity, medication use, and health status (including both selfrated status and clinically diagnosed conditions, such as arthritis, cancer, coronary heart disease, diabetes, and peripheral artery disease). From these data, Buettner et al. estimated the prevalence of self-reported musculoskeletal pain according to statin use and calculated prevalence ratio estimates of musculoskeletal pain obtained from adjusted multiple logistic regression modeling.